Peethaambaran Kunnathoor, Chennai Tuesday, July 1, 2025, 08:00 Hrs [IST] ...

Lupin forms LupinLife Consumer Healthcare with focus on OTC consumer wellness solutions: Our Bureau, Bengaluru Tuesday, July 1, 2025, 17:15 Hrs [IST] Global pharma major Lupin ann ...

ARGX-119 in congenital myasthenic syndromes: Amsterdam, the Netherlands Tuesday, July 1, 2025, 18:00 Hrs [IST] argenx SE, a global immunolo ...

Carlsbad, California Tuesday, July 1, 2025, 16:00 Hrs [IST] ...

Klotho Neurosciences moves forward with manufacturing gene therapy to treat amyotrophic lateral sclerosis: New York Tuesday, July 1, 2025, 15:00 Hrs [IST] Klotho Neurosciences, In ...

Telangana State’s pharma future hinges on strategic collaboration between industry, academia & government: KV Rambabu: Tuesday, July 1, 2025, 08:00 Hrs [IST] Telangana stands as ...

Our Bureau, Mumbai Tuesday, July 1, 2025, 12:15 Hrs [IST] ...

Addex Therapeutics leads CHF 2 million investment in Stalicla to advance precision medicine in neuropsychiatric disorders: Geneva, Switzerland Tuesday, July 1, 2025, 11:00 Hrs [IS ...

DCC asks SLAs to implement various regulatory decisions of CDSCO with priority for uniformity: Gireesh Babu, New Delhi Tuesday, July 1, 2025, 08:00 Hrs [IST] The Drugs Consultativ ...

WuXi Biologics introduces next-generation platform WuXiHigh2.0 for high-concentration biologics with protein concentration reaching 230 mg/mL: Shanghai Tuesday, July 1, 2025, 10:0 ...

Japanese MHLW grants orphan drug designation to Sanofi’s riliprubart for chronic inflammatory demyelinating polyneuropathy: Paris Tuesday, July 1, 2025, 09:00 Hrs [IST] The Mini ...

Hansa Biopharma presents positive outcomes of 5-year follow-up study of imlifidase in kidney transplantation at ESOT Congress: Lund, Sweden Tuesday, July 1, 2025, 12:00 Hrs [IST] ...